ATRAptarGroup, Inc.
What is the market doing?
No clear lean: rangebound and insiders net selling (often routine).
Rangebound, no clear trend. Price is −4% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Lightly shorted, settled Sep 15, 2026, about a week of normal trading to cover. Up 16% since the previous count, down from 3.5% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ATR is trading
AptarGroup, Inc. is −9.4% over the past year while the S&P 500 is +18%: 28 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −4.4%
vs 200-day average · below trend, but not far
- RSI (14)
- 39
RSI (14) · neutral
- Below its 52-week high
- 17%
Below its 52-week high
Details›
- Last close2026-10-09
- $120.37
- 1 monthS&P 500 +2.7%
- −2.2%
- 1 yearS&P 500 +18%
- −9.4%
- 5 yearsS&P 500 +88%
- +2.8%
- vs 50-day average$128.42
- −6.3%
- 52-week high
- $145.15
- 52-week low
- $111.94
- Annualised volatility
- 24%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$5.2M
| Year | Return |
|---|---|
| 2026 (year to date) | −0.53% |
| 2025 | −21% |
| 2024 | +29% |
| 2023 | +14% |
| 2022 | −8.9% |
| 2021 | −9.5% |
| 2020 | +20% |
| 2019 | +24% |
| 2018 | +11% |
| 2017 | +19% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +1.4% |
| Feb | 10 | 7 of 10 | +1.5% |
| Mar | 10 | 7 of 10 | +0.47% |
| Apr | 10 | 8 of 10 | +2.6% |
| May | 10 | 5 of 10 | −0.03% |
| Jun | 10 | 6 of 10 | +1.2% |
| Jul | 11 | 7 of 11 | +1.8% |
| Aug | 11 | 7 of 11 | +0.61% |
| Sep | 11 | 3 of 11 | −3.1% |
| Oct | 11 | 6 of 11 | −1.3% |
| Nov | 10 | 8 of 10 | +3.2% |
| Dec | 10 | 5 of 10 | −0.81% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Medical Instruments & Supplies
Ranks #1 of 21 by RyuScore